“The world can change overnight. We have to accept volatility as part of the world we live in.” Peter DeYoung, CEO of Piramal Global Pharma, has spent 13 years with the Piramal Group, navigating the complexities of pharmaceutical manufacturing across
Piramal Pharma Limited has taken a significant step towards its sustainability goals with the conversion of its coal-fired steam boiler to biomass briquettes at its Digwal, India facility. This change is expected to eliminate approximately 24,000 tonnes of carbon dioxide
Piramal Pharma has received official validation from the Science Based Targets Initiative (SBTi) for its near-term greenhouse gas (GHG) emission reduction targets. The company’s commitment includes reducing scope 1 and 2 emissions by 42% by FY2030, using FY2022 as the
